These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8873515)

  • 1. The substance-using human immunodeficiency virus patient: approaches to outpatient management.
    O'Connor PG; Samet JH
    Am J Med; 1996 Oct; 101(4):435-44. PubMed ID: 8873515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.
    Kresina TF; Bruce RD; Cargill VA; Cheever LW
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S83-8. PubMed ID: 16265621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone maintenance treatment (MMT): a review of historical and clinical issues.
    Joseph H; Stancliff S; Langrod J
    Mt Sinai J Med; 2000; 67(5-6):347-64. PubMed ID: 11064485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary care of parenteral substance abusers.
    Williams A
    Nurse Pract; 1986 Jun; 11(6):17, 20, 25 passim. PubMed ID: 3459065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case management of substance abusers with HIV disease.
    Schwartz B; Dilley J; Sorensen JL
    J Case Manag; 1994; 3(4):173-8. PubMed ID: 7735090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of substance users with HIV infection.
    Selwyn PA; O'Connor PG
    Prim Care; 1992 Mar; 19(1):119-56. PubMed ID: 1594693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HIV-infected drug addicts in a clinic for infectious diseases are dissatisfied and desire more treatment].
    Tokåker PO; Spångberg L; Pehrson P
    Lakartidningen; 1991 Mar; 88(12):1069, 1071-2. PubMed ID: 2016939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropsychological changes in drug addicts infected with human immunodeficiency virus].
    Sopelana P; Débora M; López-Calvo S; García-Alvarez JC; Polo C
    Arch Neurobiol (Madr); 1992; 55(5):228-34. PubMed ID: 1482276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and management of substance use in HIV primary care.
    AIDS Inst Newsl; 1995 Jun; ():1-12. PubMed ID: 11367406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus.
    Neaigus A; Miller M; Friedman SR; Des Jarlais DC
    J Infect Dis; 2001 Aug; 184(3):359-63. PubMed ID: 11443564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection.
    Dore GJ; Thomas DL
    Semin Liver Dis; 2005 Feb; 25(1):18-32. PubMed ID: 15731995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus prevention and the potential of drug abuse treatment.
    Metzger DS; Navaline H
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S451-6. PubMed ID: 14648463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
    AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers.
    De Castro S; Sabaté E
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S464-7. PubMed ID: 14648465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.
    Celentano DD; Lucas G
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S318-23. PubMed ID: 18190306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
    Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug use and HIV/AIDS in China.
    Liu Z; Lian Z; Zhao C
    Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users].
    de la Fuente L; Bravo MJ; Lew C; Barrio G; Soriano V; Royuela L
    Med Clin (Barc); 1999 Nov; 113(17):646-51. PubMed ID: 10618778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health services research: drug use and human immunodeficiency virus in the United States.
    Flanzer J
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S439-44. PubMed ID: 14648461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine use: the international experience.
    Carrieri MP; Amass L; Lucas GM; Vlahov D; Wodak A; Woody GE
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S197-215. PubMed ID: 17109307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.